Fluorescence optical imaging for treatment monitoring in patients with early and active rheumatoid arthritis in a 1-year follow-up period
Authors:
- Anne-Marie GlimmAGAnne-Marie Glimm
- Lisa Ines SprengerLSLisa Ines Sprenger
- Ida Kristin HaugenIHIda Kristin Haugen
- Ulrich MansmannUMUlrich Mansmann
- Sandra HermannSHSandra Hermann
- Thomas HäuplTHThomas Häupl
- Paula HoffPHPaula Hoff
- Gerd-Rüdiger BurmesterGBGerd-Rüdiger Burmester
- Marina BackhausMBMarina Backhaus
- Lien LeLLLien Le
- Sarah OhrndorfSOSarah Ohrndorf
Open Access
- 18 September 2019
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 21 (1) , 1-12
Abstract
Background: Fluorescence optical imaging (FOI) enables visualization of inflammation in the hands in rheumatic joint diseases with currently a lack of long-term follow-up studies. Objective: To investigate FOI for treatment monitoring in a homogenous cohort of patients with early (disease duration < 2 years) and active (DAS28 > 3.2) RA over a period of 12 months. Methods: Thirty-five RA patients (24 (68.6%) females, mean age 53.3 years (SD 13.6)) were investigated clinically by DAS28, tender joint count (TJC) and swollen joint count (SJC) and by FOI in phases 1–3 and PrimaVistaMode (PVM) before therapy change and after 12 months. The FOI activity score (FOIAS) was calculated based on individual joint scores from 0 to 3 in 30 joints per patient, adding up to a sum score (0–90). Results: We found a statistically significant reduction of FOIAS in phase 1 from baseline (median 5.0, IQR 24.96) to follow-up (median 1.0, IQR 4.0) in all patients (p = 0.0045), both in responders and non-responders according to EULAR response criteria by DAS28. Statistically significant reductions over 12 months were found for median DAS28(ESR) 5.61 to 3.31, TJC 7.0 to 1.0, and SJC 5.0 to 1.0 (each p < 0.001). No statistically significant correlations were detected between the FOIAS change in phase 1 and DAS28(ESR), TJC, or SJC. Correlations between the other phases and clinical outcomes were weak to moderate. Conclusion: Reduced early enhancement in FOI phase 1 can be observed in clinically responding and non-responding early RA patients under treatment. Regarding potential marker performance, FOI probably shows a reduction of inflammation more objectively.Keywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (Subproject No. 7)
This publication has 37 references indexed in Scilit:
- EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritisAnnals of the Rheumatic Diseases, 2013
- Advances in sonographic scoring of rheumatoid arthritisAnnals of the Rheumatic Diseases, 2013
- Inflammation assessment in patients with arthritis using a novel in vivo fluorescence optical imaging technologyAnnals of the Rheumatic Diseases, 2012
- A Review of Indocyanine Green Fluorescent Imaging in SurgeryInternational Journal of Biomedical Imaging, 2012
- Systematic Review of MRI, Ultrasound, and Scintigraphy as Outcome Measures for Structural Pathology in Interventional Therapeutic Studies of Knee Arthritis: Focus on ResponsivenessThe Journal of Rheumatology, 2010
- Indocyanine green–enhanced imaging of antigen‐induced arthritis with an integrated optical imaging/radiography systemArthritis & Rheumatism, 2010
- Arthritis of the finger joints: A comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imagingArthritis & Rheumatism, 1999
- Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary american college of rheumatology and the world health organization/international league against rheumatism criteriaArthritis & Rheumatism, 1996
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- INDOCYANINE GREEN: OBSERVATIONS ON ITS PHYSICAL PROPERTIES, PLASMA DECAY, AND HEPATIC EXTRACTION*Journal of Clinical Investigation, 1960